An Open-Label, Pharmacokinetic Study of the Safety and Tolerability of Pazopanib in Combination With FOLFOX 6 or CapeOx in Subjects With Colorectal Cancer
Phase of Trial: Phase I
Latest Information Update: 20 Nov 2017
At a glance
- Drugs Capecitabine; Fluorouracil; Folinic acid; Oxaliplatin; Pazopanib
- Indications Colorectal cancer
- Focus Pharmacokinetics
- 31 Aug 2018 Biomarkers information updated
- 24 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Feb 2010 CTRI reports trial status as completed and additional trial identifiers (UTRN034931413-060720099791266, CTRI2009-091-000516, RM2005-00583-01), trial investigators added.